Cepheid (CPHD)

34.32
0.75 2.10
NASDAQ : Technology
Prev Close 35.07
Open 35.09
Day Low/High 34.01 / 35.43
52 Wk Low/High 25.09 / 53.19
Volume 340.40K
Avg Volume 697.40K
Exchange NASDAQ
Shares Outstanding 73.01M
Market Cap 2.55B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

'Mad Money' Lightning Round: I'm Still With Opko Health

'Mad Money' Lightning Round: I'm Still With Opko Health

Cramer wants you to stick with Abbvie and says Cepheid is working.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

These 2 Undervalued Health Care Stocks Are Poised to Break Higher

These 2 Undervalued Health Care Stocks Are Poised to Break Higher

Shares of Cepheid and Hologic are oversold and are on their way up.

Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services

Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services

Hammersmith Broadway is Next in a Series of Clinics to Offer Fast and Discrete Testing.

FDA Supports Expanded Claims For Xpert Carba-R Test For

FDA Supports Expanded Claims For Xpert Carba-R Test For "Superbugs"

Xpert Carba-R Test is the First FDA-Cleared Molecular Test for Rapid Detection of Carbapenemase Producing Organisms Directly from Rectal Swab Specimens

Cepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test

Cepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test

Broadens Access to Critical Diagnostic Results for Infants Born with HIV

Bearish Bets: 5 Retail, Industrial and Education Stocks That Look Good Short

FOSL, CPHD, BWA, BPI and AP were all recently downgraded by TheStreet’s Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AF, ANET, CCU, CROX, ENBL, GRBK, HCCI, LBTYA, PFIN, RIGP, TIME, UNAM, ZION Downgrades: ABEV, BPI, CPHD, LEE, PBIP, UG Initiations: HTGM, OPGN Read on to get TheStreet Quant Ratings' detailed report:

Today's Dead Cat Bounce Stock: Cepheid (CPHD)

Today's Dead Cat Bounce Stock: Cepheid (CPHD)

Trade-Ideas LLC identified Cepheid (CPHD) as a "dead cat bounce" (down big yesterday but up big today) candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIRM, AKS, AVX, AWH, BWA, CPHD, CVV, DD, EMXX, MAS, NANO, NTP, PEBO, PMD, PNR, POL, QLIK, SRDX, STAY, TILE, WCC, WWW, ZIXI Downgrades: ARI, CTG, STL Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Cepheid Announces Partner Distribution Agreement With Medline

Cepheid Announces Partner Distribution Agreement With Medline

Further Broadens Reach of GeneXpert System into Non-Acute Market in United States

Cepheid (CPHD) Stock Price Target Upped at Canaccord

Cepheid (CPHD) Stock Price Target Upped at Canaccord

Cepheid’s (CPHD) price target was increased at Canaccord, which also maintained its ‘hold’ rating on the stock.

Analysts' Actions -- Gap, Genuine Parts, Square, Intuitive Surgical and More

Analysts' Actions -- Gap, Genuine Parts, Square, Intuitive Surgical and More

Here are Monday's top research calls, including an upgrade for Gap, and downgrades for Genuine Parts, Intuitive Surgical and Square.

Cepheid Announces European Approval Of Xpert MRSA Next Generation (NxG) Screening Test

Cepheid Announces European Approval Of Xpert MRSA Next Generation (NxG) Screening Test

The Number One, On-Demand Molecular Test for MRSA Colonization is Now Improved

Cepheid Announces First FDA-Cleared Test For Detection Of Carbapenem Resistance Genes In Isolates Of Multidrug Resistant 'Superbugs'

Cepheid Announces First FDA-Cleared Test For Detection Of Carbapenem Resistance Genes In Isolates Of Multidrug Resistant 'Superbugs'

Xpert Carba-R Results in Less Than an Hour Help to Prevent and Manage Outbreaks

Cepheid Delivers Milestone 10,000th GeneXpert System

Cepheid Delivers Milestone 10,000th GeneXpert System

Dean Street Express Expanding to Additional Locations using GeneXpert Infinity System

Short Interest Drops 12.6% For CPHD

Short Interest Drops 12.6% For CPHD

The most recent short interest data has been released by the NASDAQ for the 02/12/2016 settlement date, which shows a 710,766 share decrease in total short interest for Cepheid , to 4,936,354, a decrease of 12.59% since 01/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trade-Ideas: Cepheid (CPHD) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Cepheid (CPHD) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Cepheid (CPHD) as a strong on high relative volume candidate

Cepheid (CPHD) Highlighted As Today's Perilous Reversal Stock

Cepheid (CPHD) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Cepheid (CPHD) as a "perilous reversal" (up big yesterday but down big today) candidate

New 52-Week Low Could Prompt More Insider Buying At CPHD

New 52-Week Low Could Prompt More Insider Buying At CPHD

In trading on Thursday, shares of Cepheid touched a new 52-week low of $28.33/share. That's a $35.36 share price drop, or -55.52% decline from the 52-week high of $63.69 set back on 07/20/2015.